Circulation Acceptance Rate

Source: Clarivate JCR (2016-2024 reported figures).

The fastest desk rejections happen when a paper is fundamentally basic cardiovascular science. A study of cardiac ion channel regulation at the molecular level, without any clinical bridge, belongs at Circulation Research JIF 18, not Circulation. The editors make this distinction quickly.

Papers that survive the desk typically answer "yes" to this question: would a practicing cardiologist read this and consider changing something about how they treat patients or interpret cardiovascular risk?

That doesn't mean the paper has to be a clinical trial. Translational work counts. But the translational bridge needs to be visible, not theoretical.

Circulation's unusual front-door signal is the Clinical Perspective that the AHA asks Original Research authors to include:

• What Is New?

• What Are the Clinical Implications?

If those bullets are generic, hedged, or basically a second abstract, editors often infer that the manuscript itself is not yet carrying a flagship-level consequence cleanly enough.

Among papers that enter review, rejection usually comes from:

• The clinical endpoints aren't strong enough (surrogate markers instead of hard outcomes)

• The study design has limitations that undermine the clinical conclusion

• The population is too narrow for Circulation's broad cardiovascular readership

• The finding replicates what's already known without adding a meaningful new dimension

Circulation sits atop the AHA journal family. When editors see merit but not flagship-level importance, they often offer to transfer to Circulation: Heart Failure, Circulation: Arrhythmia, or another specialty title. These are respected journals in their own right (IFs 9-25), and the transfer typically comes with the editor's recommendation.

Taking the transfer seriously is often the right move. A paper that's borderline for Circulation may be a strong acceptance at a specialty title.

The useful interpretation is not that Circulation is impossible. It is that the journal is choosing for a very specific shape of paper:

• broad cardiovascular consequence

• clear clinical or translational bridge

• a package strong enough to survive a fast first read

That is why the same manuscript can be a quick no at Circulation and then a strong yes at a Circulation specialty journal. The science may be sound. The flagship fit may simply be wrong.

Submit if:

• the finding changes how cardiologists understand or treat cardiovascular disease

• the evidence is clinical or has a clear translational bridge to patient care

• the study population and endpoints are broad enough for the AHA's flagship readership

• you're comfortable with the AHA family cascade if the paper doesn't clear the flagship

Think twice if:

• the paper is primarily basic cardiovascular biology (Circulation Research is the better target)

• the finding is specific to one cardiovascular subspecialty (a Circulation specialty title may fit better)

• European Heart Journal or JACC would reach your target audience more effectively

• the clinical implications are speculative rather than evidence-supported

A Circulation submission readiness check can help assess whether the cardiovascular framing meets Circulation's clinical threshold before you submit.

Of the cardiovascular manuscripts our team reviewed before Circulation submission, three named rejection patterns account for the majority of desk returns. Editors at Circulation consistently reject papers on these three patterns within the AHA's 17-day first-decision window. What we observe in our internal analysis is that editorial culture at the AHA flagship requires that the clinical bridge be explicit, central, and stated in a way a practicing cardiologist could act on.

The patterns below reflect what we see, what editors actually screen for, and what hidden filters apply at the desk. Each is a specific, named failure pattern that authors can check their own manuscript against.

Basic cardiovascular biology without a clinical or translational bridge.

Circulation's author instructions say the journal "covers basic, translational, clinical, and population health research." In practice, the editorial bar requires that the clinical bridge be explicit and central, not theoretical. The failure pattern is a paper on cardiac ion channel regulation, intracellular calcium signaling, mitochondrial function in cardiomyocytes, or molecular mechanisms of cardiac fibrosis where the scientific quality is high but the connection to a patient-care decision is aspirational.

Editors desk-reject these papers within days and redirect them to Circulation Research JIF 18, which specifically covers basic cardiovascular science. Papers must demonstrate either that the advance comes from a clinical or translational study, or that the mechanistic finding is directly connected to a therapeutic or diagnostic consequence in the manuscript itself.

Clinical Perspective entries that are generic or hedged. Circulation asks authors to include a Clinical Perspective in Original Research manuscripts, with two specific entries:

"What Is New?" and "What Are the Clinical Implications?" The failure pattern is Clinical Perspective entries that describe the study methods or findings in slightly different words from the abstract, list broadly applicable statements about cardiovascular risk, or hedge clinical implications with language like "may potentially improve outcomes" or "could represent a future target." Editors treat weak Clinical Perspective boxes as evidence that the clinical consequence was not strong enough to state plainly.

The entries should be specific enough that a cardiologist could read them and immediately identify what to do differently for their patients.

Finding relevant only to one cardiovascular subspecialty. Circulation serves the broad cardiovascular community: general cardiologists, interventional cardiologists, electrophysiologists, heart failure specialists, and preventive cardiologists all read it.

The failure pattern is a paper whose findings are primarily relevant to one subspecialty group, such as an electrophysiology mapping study that only arrhythmia specialists would find actionable, a heart failure device study that only heart failure cardiologists would read, or a coronary intervention technique paper with limited relevance beyond interventional labs.

Editors redirect subspecialty-specific papers to Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, or Circulation: Cardiovascular Interventions rather than desk-rejecting the science. A Circulation submission readiness check can identify whether the cardiovascular consequence is broad enough for the flagship before submission.

The acceptance rate for Circulation does not distinguish between desk rejections and post-review rejections. A paper desk-rejected in 2 weeks and a paper rejected after 4 months of review both count the same. The rate also does not reveal how acceptance varies by article type, geographic origin, or research area within the journal's scope.

Acceptance rates cannot predict your individual odds. A strong paper with clear scope fit, complete data, and solid methodology has substantially better odds than the headline number suggests. A weak paper with methodology gaps will be rejected regardless of the journal's overall rate.

A Circulation submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.